home / stock / imnp / imnp quote
Last: | $ |
---|---|
Change Percent: | -39.62% |
Open: | $0.0045 |
Close: | $0.0032 |
High: | $0.0051 |
Low: | $0.0023 |
Volume: | 29,099,001 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.0045 | $0.0032 | $0.0051 | $0.0023 | 29,099,001 | 02-19-2019 |
$ | $0.005 | $0.0053 | $0.006 | $0.0047 | 13,859,196 | 02-18-2019 |
$ | $0.005 | $0.0053 | $0.006 | $0.0047 | 13,859,196 | 02-15-2019 |
$ | $0.0074 | $0.0066 | $0.0074 | $0.0063 | 2,408,163 | 02-14-2019 |
$ | $0.0074 | $0.0069 | $0.0074 | $0.0063 | 656,484 | 02-13-2019 |
$ | $0.0066 | $0.007 | $0.007 | $0.006 | 1,087,962 | 02-12-2019 |
$ | $0.00795 | $0.0063 | $0.00795 | $0.0055 | 3,995,423 | 02-11-2019 |
$ | $0.0062 | $0.00652 | $0.007 | $0.0061 | 2,987,000 | 02-08-2019 |
$ | $0.008 | $0.008 | $0.008 | $0.0068 | 3,110,474 | 02-07-2019 |
$ | $0.009 | $0.0083 | $0.009 | $0.0078 | 4,576,891 | 02-06-2019 |
$ | $0.00756 | $0.0078 | $0.009 | $0.0075 | 1,788,401 | 02-05-2019 |
$ | $0.0069 | $0.0078 | $0.0095 | $0.0069 | 3,520,770 | 02-04-2019 |
$ | $0.0074 | $0.0075 | $0.00765 | $0.0066 | 1,764,098 | 02-01-2019 |
$ | $0.01225 | $0.0074 | $0.01225 | $0.0072 | 6,340,071 | 01-31-2019 |
$ | $0.00815 | $0.00809 | $0.0088 | $0.0072 | 9,068,645 | 01-30-2019 |
$ | $0.0064 | $0.008 | $0.00885 | $0.0061 | 8,317,574 | 01-29-2019 |
$ | $0.00565 | $0.006 | $0.0065 | $0.0051 | 6,146,843 | 01-28-2019 |
$ | $0.0072 | $0.0056 | $0.0072 | $0.0051 | 8,766,182 | 01-25-2019 |
$ | $0.00685 | $0.0065 | $0.008 | $0.006 | 6,615,254 | 01-24-2019 |
$ | $0.0065 | $0.0062 | $0.0072 | $0.0052 | 4,686,048 | 01-23-2019 |
News, Short Squeeze, Breakout and More Instantly...
Immune Pharmaceuticals Inc. Company Name:
IMNP Stock Symbol:
OTCMKTS Market:
Immune Pharmaceuticals Inc. Website:
FORT LEE, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, has filed for...